GPCR – structure therapeutics inc. (US:NASDAQ)
Stock Stats
News
Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target [Seeking Alpha]
Structure Therapeutics (GPCR) had its "outperform" rating reaffirmed by William Blair.
Structure Therapeutics Inc. (GPCR) Discusses Positive Topline Results from ACCESS II and Related Studies of Aleniglipron Oral GLP-1 Transcript [Seeking Alpha]
Structure Therapeutics (GPCR) had its price target lowered by HC Wainwright from $114.00 to $100.00. They now have a "buy" rating on the stock.
Structure Therapeutics (GPCR) had its "outperform" rating reaffirmed by Leerink Partners.
Form 8-K Structure Therapeutics For: Mar 16
Form 4 Structure Therapeutics For: Mar 03 Filed by: Coll Crespo Blas
Form 4 Structure Therapeutics For: Mar 03 Filed by: Lin Xichen
Form 4 Structure Therapeutics For: Mar 03 Filed by: Hall Ashley
Form 4 Structure Therapeutics For: Mar 03 Filed by: Ma Yingli
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.